List of pharmaceutical specialities - Interpharma

Putting the focus on patients

List of pharmaceutical specialities

The process of manufacturing a medicinal product involves investments and risks.

Overview Biologicals and biosimilars Generics List of pharmaceutical specialities Paediatric medicinal products Parallel imports Regulation of medicinal products The Pharma Cooperation Code Use of medicinal products

The health insurance providers only reimburse the cost of a medicinal product as part of the statutory health insurance mandated by the Health Insurance Act (HIA) if it has been prescribed by a doctor and is on the List of pharmaceutical specialities (LS) managed by the Federal Office of Public Health (FOPH). Patients have to pay themselves for medicines not on the LS, or they are reimbursed through additional insurance that patients can take out voluntarily. Reimbursement in individual cases is regulated in Art. 71a-d of the HIO.

Only authorised medicinal products are included

The FOPH only includes medicinal products authorised by Swissmedic in its LS. They must also be effective, appropriate and cost-effective. The FOPH examines effectiveness on the basis of the documents that were decisive in Swissmedic’s decision to authorise the product. A medicinal product is considered to be cost-effective if it ensures the indicated, i.e. recognised by Swissmedic, curative effect with as little financial outlay as possible. The FOPH generally consults the Federal Medicines Commission (FMC) before it decides whether to include a medicinal product in the LS. In the outpatient setting (i.e. outside of hospitals) only medicinal products on the LS may be prescribed and dispensed at the expense of the statutory health insurance system. In hospitals, medicines that are not available in the outpatient setting (e.g. prepared within the hospital) may also be used and reimbursed by the statutory health insurance system.

Further information

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2023

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more


Contact us

read more


Latest information and media contacts for media representatives

read more